论文部分内容阅读
急性脑梗塞为最常见的脑血管病,近年来我国脑梗塞的发病率、致残率、致死率持续升高,且呈现低龄化趋势。蚓激酶胶囊是一种口服抗栓溶栓药物。我院自2001年1月至2001年6月给急性脑梗塞病人口服蚓激酶胶囊(商品名:百奥蚓激酶胶囊),现将观察结果报告如下:1 临床资料1.1 研究对象 本组60例均为我院2001年1月至2001年6月患急性脑梗塞的住院病人。依据1986年我国第二次脑
Acute cerebral infarction is the most common cerebrovascular disease. In recent years, the morbidity, morbidity and mortality of cerebral infarction in our country have been continuously increased, and the tendency of younger age appears. Lumbrokinase capsules are oral antithrombotic thrombolytic drugs. Our hospital from January 2001 to June 2001 for patients with acute cerebral infarction Lumbukinase capsules (trade name: Hundred Lumbuke kinase capsules), the observation results are reported as follows: 1 clinical data 1.1 The study group of 60 patients were For our hospital from January 2001 to June 2001 suffering from acute cerebral infarction inpatients. According to 1986 our second brain